Hollow Brook Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Hold
3,546
0.09% 68
2026
Q1
$494K Sell
3,546
-888
-20% -$124K 0.13% 61
2025
Q4
$544K Sell
4,434
-336
-7% -$40.8K 0.14% 62
2025
Q3
$529K Buy
4,770
+336
+8% +$38.2K 0.13% 69
2025
Q2
$492K Hold
4,434
0.14% 61
2025
Q1
$497K Hold
4,434
0.15% 59
2024
Q4
$410K Hold
4,434
0.13% 66
2024
Q3
$372K Buy
4,434
+834
+23% +$63.6K 0.11% 71
2024
Q2
$247K Hold
3,600
0.08% 68
2024
Q1
$264K Hold
3,600
0.1% 70
2023
Q4
$292K Hold
3,600
0.12% 69
2023
Q3
$270K Hold
3,600
0.11% 72
2023
Q2
$277K Hold
3,600
0.12% 74
2023
Q1
$299K Hold
3,600
0.14% 69
2022
Q4
$309K Hold
3,600
0.15% 68
2022
Q3
$222K Hold
3,600
0.13% 69
2022
Q2
$223K Hold
3,600
0.12% 67
2022
Q1
$214K Sell
3,600
-29,194
-89% -$1.87M 0.1% 71
2021
Q4
$2.38M Buy
32,794
+102
+0.3% +$7.03K 1.22% 22
2021
Q3
$2.28M Sell
32,692
-378
-1% -$26.6K 1.42% 20
2021
Q2
$2.28M Sell
33,070
-252
-0.8% -$16.8K 1.42% 19
2021
Q1
$2.15M Sell
33,322
-24,749
-43% -$1.6M 1.41% 19
2020
Q4
$3.38M Sell
58,071
-2,242
-4% -$135K 2.02% 13
2020
Q3
$3.81M Sell
60,313
-259
-0.4% -$18K 2.38% 8
2020
Q2
$4.66M Buy
60,572
+1,400
+2% +$107K 3.57% 6
2020
Q1
$4.42M Sell
59,172
-3,787
-6% -$262K 4.13% 5
2019
Q4
$4.09M Sell
62,959
-1,166
-2% -$75.9K 2.13% 10
2019
Q3
$4.06M Sell
64,125
-2,053
-3% -$134K 2.73% 9
2019
Q2
$4.47M Buy
66,178
+150
+0.2% +$9.87K 4.06% 7
2019
Q1
$4.29M Sell
66,028
-4,772
-7% -$317K 4.65% 6
2018
Q4
$4.43M Sell
70,800
-1,728
-2% -$121K 4.73% 8
2018
Q3
$5.6M Sell
72,528
-1,500
-2% -$113K 4.38% 7
2018
Q2
$5.24M Buy
74,028
+7,514
+11% +$531K 4.14% 8
2018
Q1
$5.01M Sell
66,514
-8,373
-11% -$666K 4.02% 9
2017
Q4
$5.37M Sell
74,887
-9,223
-11% -$700K 3.94% 9
2017
Q3
$6.82M Sell
84,110
-85,541
-50% -$6.54M 4.98% 6
2017
Q2
$12M Buy
169,651
+395
+0.2% +$26.3K 8.25% 1
2017
Q1
$11.5M Sell
169,256
-19,911
-11% -$1.4M 8.95% 2
2016
Q4
$13.5M Sell
189,167
-1,332
-0.7% -$99K 8.37% 2
2016
Q3
$15.1M Buy
190,499
+8,663
+5% +$704K 8.91% 1
2016
Q2
$15.2M Sell
181,836
-21,704
-11% -$1.93M 10.5% 1
2016
Q1
$18.7M Sell
203,540
-21,328
-9% -$1.92M 11.15% 1
2015
Q4
$22.8M Sell
224,868
-14,605
-6% -$1.52M 11.29% 1
2015
Q3
$23.5M Sell
239,473
-1,421
-0.6% -$158K 11.22% 1
2015
Q2
$28.2M Sell
240,894
-22,939
-9% -$2.51M 10.79% 1
2015
Q1
$25.9M Sell
263,833
-7,848
-3% -$797K 8.59% 2
2014
Q4
$25.6M Sell
271,681
-4,821
-2% -$499K 8.29% 3
2014
Q3
$29.4M Buy
276,502
+3,300
+1% +$323K 9.63% 1
2014
Q2
$22.7M Buy
273,202
+2,511
+0.9% +$195K 7.7% 2
2014
Q1
$19.2M Sell
270,691
-80,607
-23% -$6.32M 6.27% 3
2013
Q4
$26.4M Sell
351,298
-5,291
-1% -$368K 8.65% 2
2013
Q3
$22.4M Sell
356,589
-10,537
-3% -$630K 7.85% 2
2013
Q2
$18.8M Buy
+367,126
New +$19.1M 6.94% 2

Other funds holding GILD

Hollow Brook Wealth Management's GILD Position: Q2 2026 in Review

Hollow Brook Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,546 shares worth $448K. The position accounts for 0.09% of the portfolio, ranked #68.

Hollow Brook Wealth Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.4M in Q3 2014. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hollow Brook Wealth Management held 3,546 shares of Gilead Sciences worth $448K as of Q2 2026.
  • Hollow Brook Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.09% of Hollow Brook Wealth Management's portfolio in Q2 2026, its #68 holding.
  • Hollow Brook Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Hollow Brook Wealth Management's Gilead Sciences position peaked at $29.4M in Q3 2014.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hollow Brook Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.